Dr. Krenács László. Publikációs jegyzék

Size: px
Start display at page:

Download "Dr. Krenács László. Publikációs jegyzék"

Transcription

1 2007

2 Tartalom 1. Könyvfejezetek 3. oldal 2. Tudományos cikkek lektorált folyóiratokban 4. oldal 3. Nemzetközi konferenciák összefoglalói folyóiratokban 8. oldal 4. Nemzetközi konferenciák kiadványai 10. oldal 5. Magyar nyelvű előadások hazai kongresszusokon 12. oldal 2

3 DR. KRENÁCS LÁSZLÓ TUDOMÁNYOS PUBLIKÁCIÓS JEGYZÉKE Könyvfejezetek 1. Krenács L. T-sejtes prolymphocytás lymphoma. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 2. Krenács L. Extranodális NK/T-sejtes lymphoma, nasalis típus. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 3. Krenács L. Enteropathia típusú T-sejtes lymphoma. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 4. Krenács L. Mycosis fungoides és Sezary-szindróma. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 5. Krenács L. Primer CD30 pozitív cutan T-sejtes lymphoproliferativ betegségek. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 6. Krenács L. Angioimmunoblastos T-sejtes lymphoma. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 7. Krenács L. Perifériás T-sejtes lymphoma, tovább nem osztályozott. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 8. Krenács L. Mastocytosisok. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 9. Krenács L. Immunhisztokémia. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 10. Krenács T, Krenács L. Immunogold-silver staining (IGSS) for immunoelectron microscopy and in multiple detection affinity cytochemistry. In: Gu J, ed. Modern Analytical Methods in analytical morphology (Gu J. and Hacker G.W. eds.) New York, (1994), Plenum Press, New York, o. 11. Krenács T, Krenács L. Comparison of embedding media for immunogold-silver staining. In: Immunogold-silver staining. Principles, methods and applications (M.A. Hayat ed.) CRC Press, (1995), Boca Raton, o. 12. Krenács L, Krenács T, Raffeld M. Antigen retrieval for immunohistochemistry in routinely processed paraffin sections. In: Methods in molecular biology: Immunohistochemical methods and protocols. (Javois L.C. ed.) Totowa, NJ, USA, Humana Press Inc. 2 nd edition. 115:85-93 (1999) 3

4 13. Krenács T, Krenács L, Raffeld M. Immunostaining procedures for multiple antigen detection. In: Methods in molecular biology: Immunohistochemical methods and protocols. (Javois L.C. ed.) Ed Javois LC Totowa, NJ, USA, Humana Press Inc. 2 nd edition. 115: (1999) 14. Krenács L, Bagdi E, Krenács T. Immunocytopathology of Lymphomas. In: Theory and Practice of Histological Techniques, 5 th edition, (Bancroft and Gamble eds.) Edinburgh, (2001), Churchill-Livingstone, o. 15. Demeter J, Krenács L. Hajas sejtes leukemia. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 16. Radványi G, Tarkovács G, Krenács L. Plazmasejtes daganatok. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 17. Borbényi Z, Krenács L. Marginális zóna lymphoma. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. 18. Varga Gy, Krenács L. Diffúz nagy B-sejtes lymphoma. Hematológiai Betegségek Atlasza (Szerk.: Matolcsy A., Udvardy M., Kopper L.), Budapest, (2006), Medicina Könyvkiadó Rt., o. Tudományos cikkek lektorált folyóiratokban 1. Friedrich T, Magyarlaki T, Krenács L. Chlorome des intestinaltraktes DER PATHOLOGE 10: (1989) IF: 0, Tószegi A, Krenács L, Bahn H, Molnár E, Dux L. Endomyocardiális biopsiás minták morfológiai vizsgálata. MORPHOL IGAZSÁGÜGYI ORV SZ 29: (1989) 3. Krenács T, Stiller D, Krenács L, Bahn H, Molnár E, Dux L. Sarcoplasmic reticulum (SR) Ca 2+ -ATPase as a marker of muscle-cell differentiation. immunohistochemical investigations of rhabdomyosarcomas and enhancement of immunostaining after sodium methoxide treatment. ACTA HISTOCHEM 88: (1990) IF: 0, Krenács T, Krenács L, Bozóky B, Iványi B. Double and triple immunocytochemical labelling at a light microscopic level in histopathology. HISTOCHEM J 22: (1990) IF: 1, Krenács T, Iványi B, Bozóky B, Lászik Z, Krenács L, Rázga Zs, Ormos J. Postembedding immunoelectron microscopy using immunogold-silver staining (IGSS) in Epon 812, Durcupan ACM and LR-White resin embedded tissues. J HISTOTECHNOL 14: (1991) IF: 0, Mándi Y, Endrész V, Krenács L, Régely K, Degre M, Béládi I. Tumor necrosis factor production by human granulocytes. INT ARCH ALLERGY APPL IMMUNOL 96: (1991) IF: 1,101 4

5 7. Sandvej K, Krenács L, Hamilton-Dutoit SJ, Rindum JL, Pindborg JJ, Pallesen G. Epstein- Barr virus latent and replicative gene expression in oral hairy leukoplakia. HISTOPATHOL 20: (1992) IF: 1, Szalontai K, Krenács L, Csanádi J, Ugocsai K, Kraszkó P. A tüdő lymphoid infiltrátumairól. ORV HETIL 134: (1993) 9. Baráth B, Krenács L, Bodosi M. Multiplex agy- és gerincvelő-daganat neurofibromatosis részjelenségeként. CLIN NEUROSCI/IDEGGY SZLE 46: (1993) 10. Krenács L, Tiszlavicz L, Krenács T, Boumsell L. Immunohistochemical detection of CD1a antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J PATHOL 171: (1993) IF: 3, Kurucz E, Glávits R, Krenács L, Krenács T, Ocsovszky I, Keresztes G, Monostori É, Andó I. An antiserum reacts with an evolutionary conserved region in the epsilon subunit of the T- cell receptor-cd3 complex in phylogenetically distant species. IMMUNOL LETTERS 38: (1993) IF: 1, Vajtai I, Sümegi V, Krenács L, Varga Zs, Kuk I, Vörös E. Elsődleges agyi T-sejtes lymphoma. ORV HETIL 137: (1996) 13. Mándy Y, Nagy I, Krenács L, Ocsovszky I, Nagy Zs. Relevance of ICAM-1 to alcoholoc liver cirrhosis. PATHOBIOLOGY 64: (1996) IF: 0, Keresztes G, Glávits R, Krenács L, Kurucz É, Andó I. An anti-cd3e serum detecs T lymphocytes in paraffin-embedded pathological tissues in many animal species. IMMUNOL LETTERS 50: (1996) IF: 1, Kumar S, Krenács L, Otsuki T, Kumar D, Harris CA, Wellmann A, Jaffe ES, Raffeld M. Bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. AM J CLIN PATHOL 105: (1996) IF: 2, Krenács T, Krenács L, Bagdi E. Diagnostic immunohistochemistry in Araldite-embedded bone marrow biopsies. J CELL PATHOL 1: (1996) 17. Krenács L, Harris CA, Raffeld M, Jaffe ES. Immunohistochemical diagnosis of T-cell lymphomas in paraffin sections. J CELL PATHOL 1: (1996) 18. Cooke CB, Krenács L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES. Hepatosplenic T cell lymphoma. distinct clinicopathologic entity of cytotoxic γδ origin. BLOOD 88: (1996) IF: 9, Tiszlavicz L, Krenács L, Kovács K, Csanádi J, Szalontai K. A tüdő Langerhans-sejtes granulomatosis (morfológiai vizsgálatok histiocytosis X-ben szenvedő betegekből származó tüdőbiopsiás anyagokon). ORV HETIL 138: (1997) 20. Wellmann A, Krenács L, Fest T, Scherf U, Pastan I, Raffeld M, Brinkmann U. Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms. AM J PATHOL 150: (1997) IF: 6, Krenács L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, Raffeld M. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin s disease. evidence for distinct cellular origin. BLOOD 89: (1997) IF: 9, Jaffe ES, Krenács L, Raffeld M. Classification of T-cell and NK-cell neoplasms based on the REAL Classification. ANN ONCOL 8(Suppl2): S17-24 (1997) IF: 2,548 5

6 23. Kumar S, Krenács L, Elenitoba-Johnson KSJ, Greiner TC, Sorbara L, Kingma DW, Raffeld M, Jaffe ES. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. HUMAN PATHOL 29: (1998) IF: 2, Krenács L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in reactive B-cells and in subsets of B-cell lymphomas. BLOOD 92: (1998) IF: 8, Elenitoba KSJ, Zarate-Osorno A, Meneses A, Krenács L, Kingma DW, Raffeld M. Cytotoxic granular protein expression, EBV strain type and LMP-1 oncogene deletions in nasal T/NK cell lymphomas from Mexico. MODERN PATHOL 11: (1998) IF: 2, Croxatto HB, Kovács L, Massai R, Resch BA, Funtealba B, Salvatierra AM, Croxatto HD, Zalányi S, Viski S, Krenács L. Effects of long-term low-dose mifeprostone on reproductive function in women. HUMAN REPROD 13: (1998) IF: 3, Török L, Kirschner Á, Gurzó M, Krenács L. Leukaemiás neutrophil dermatosis. ORV HETIL 140: (1999) 28. László T, Csernus B, Krenács L, Kelényi G, Matolcsy A. Pathologic diagnosis of mantle cell lymphoma based on histologic, cytologic, immunohistologic and genetic characteristics (article in Hungarian). ORV HETIL 26: (1999) 29. Jaffe ES, Krenács L, Kumar S, Kingma DW, Raffeld M. Extranodal peripheral T-cell and NK-cell neoplasms. AM J CLIN PATHOL 111(Suppl1): S46-S55 (1999) IF: 2, Quintanilla-Martinez L, Franklin KN, Guerrero I, Krenács L, Naresh LN, Rama-Rao C, Bhatia K, Raffeld M, Magrath IT. Histological and immunophenotypic profile Nasal NK/Tcell lymphomas from Peru. High prevalence of p53 overexpression. HUMAN PATHOL 30: (1999) IF: 2, Campo E, Miguel R, Krenács L, Sorbara L, Raffeld M, Jaffe ES. Primary nodal marginal zone lymphomas of splenic and MALT types. AM J SURG PATHOL 23: (1999) IF: 3,916 A PhD fokozat megszerzését követő időszak kutatói munkájának eredményei: 32. Török L, Kirschner Á, Gurzó M, Krenács L. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis EUR J DERMAT 10: (2000) IF: 0, Bagdi E, Krenács L, Krenács T, Miller K, Isaacson PG. Follicular dendritic cells in reactive and neoplastic lymphoid tissues. a re-evaluation of staining patterns of CD21, CD23 and CD35 antibodies in paraffin sections after wet-heat induced epitope retrieval. APPL IMMUNOHISTOCHEM MOL MORPH 9: (2001) IF: 0, Török L, Gurbity PT, Kirschner Á, Krenács L. Klinikailag alopecia formájában manifesztálódó panniculitis-szerű T-sejtes lymphoma. ORV HETIL 143: (2002) 35. Kros JM, Bagdi E, Zheng P, Hop WC, Driesse MJ, Krenács L, Dinjens W. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma. J NEUROSURG 97: (2002) IF: 2, Török L, Gurbity TP, Kirschner Á, Krenács L. Panniculitis-like T-cell lymphoma clinically manifested as alopecia. BR J DERMATOL 147: (2002) IF: 2,696 6

7 37. Illés Á, Krenács L, Borbényi Z. Folliculáris lymphoma. ORV HETIL 144: (2003) 38. Krenács L, Smyth MJ, Bagdi E, Krenács T, Kopper L, Rüdiger T, Zettl A, Müller- Hermelink HK, Jaffe ES, Raffeld M. The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell and intestinal T-cell lymphomas. evidence of origin from lymphocytes involved in innate immunity. BLOOD 101: (2003) IF: 10, Gurbity TP, Bagdi E, Groen NA, Budel LM, Abbou M, Krenács L, Dinjens WNM. Increased sensitivity of B-cell clonality analysis in formalin-fixed and paraffin-embedded B- cell lymphoma samples using an enzyme blend with both 5' 3' DNA polymerase and 3' 5' exonuclease activity. VIRCHOWS ARCH 443: (2003) IF: 2, Jaffe ES, Krenács L, Raffeld M. Classification of Cytotoxic T-cell and NK-cell Lymphomas. SEMIN HEMATOL 40: (2003) IF: 3, Török L, Krenács L, Kocsis L, Gurzó M, Bagdi E, Varga Gy, Gogolák P. Agranuláris CD4+/CD56+ haematodermicus neoplasma. ORV HETIL 146: (2005) 42. Kovács GL, Stelkovics É, Krenács L, Gonda G, Goth M, Kovács L, Görömbey Z, Hubina E, Szabolcs I. Low Level of Cyclin D1 Protein Expression in Thyroid Microcarcinomas from an Autopsy Series. ENDOCRINE 26: (2005) IF: 1, Görbe A, Becker DL, Dux L, Stelkovics É, Krenács L, Bagdi E, Krenács T. Transient upregulation of connexin43 gap junctions and synchronized cell cycle control precede myoblast fusion in regenerating skeletal muscle in vivo. HISTOCHEM CELL BIOL 123: (2005) IF: 2, Krenács T, Bagdi E, Stelkovics É, Bereczki L, Krenács L. How we process trephine biopsy specimens. epoxy resin embedded bone marrow biopsies J CLIN PATHOL 58: (2005) IF: 2, Glud SZ, Sorensen AB, Andrulis M, Wang B, Kondo E, Jessen R, Krenács L, Stelkovics É, Wabl M, Serfling E, Palmetshofer A, Pedersen FS. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. BLOOD 106: (2005) IF: 10, Geissinger E, Bonzheim I, Krenács L, Roth S, Ströbel P, Ott G, Reimer P, Wilhelm M, Müller-Hermelink HK, Rüdiger T. Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistochemical detection with T-cell receptor beta chain variable region segment-specific antibodies. J MOL DIAGN 7: (2005) IF: 2, Olajos J, Füle E, Erfan J, Krenács L, Stelkovics É, Francz M, Lengyel E, Al-Frahat Y, Ésik O. Familial clustering of nasopharyngeal carcinoma in a non-endemic geographical region Report of two Hungarian cases and a review of the literature. ACTA OTOLARYNGOL 125: (2005) IF: 0, Török L, Krenács L, Kocsis L, Németh Sz, Bagdi E. A parapsoriasis és mycosis fungoides kapcsolata. Az immunmorphologiai és molekuláris biológiai vizsgálatok jelentősége. BŐRGY VENER SZEMLE 82: (2006) 49. Görbe A, Becker DL, Dux L, Krenács L, Krenács T. In differentiating prefusion myoblasts connexin43 gap junction coupling is upregulated before myoblast alignment then reduced in post-mitotic cells. HISTOCHEM CELL BIOL 125: (2006) IF: 2,239 7

8 50. Krenács L, Schaerli P, Kis Gy, Bagdi E. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. BLOOD 108: (2006) IF: 10, Geissinger E, Bonzheim I, Krenács L, Roth S, Reimer P, Wilhelm M, Müller-Hermelink HK, Rüdiger T. Nodal Peripheral T-cell lymphomas correspnd to distinct mature T-cell populations. J PATHOL 210: (2006) IF: 6, Tamáska J, Ádám E, Kozma A, Gopcsa L, Andrikovics H, Tordai A, Halm G, Bereczki L, Bagdi E, Krenács L. Hepatosplenic gd T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration. VIRCHOWS ARCH 449: (2006) IF: 2, Váróczy L, Illés Á, Gergely L, Simon Z, Bassam A, Krenács L. Uncommon lymphadenopathies can be misinterpreted as malignant disease. RHEUMATHOL INT Dec12; {Epub ahead of print} (2006) IF: 1,477 Nemzetközi konferenciák összefoglalói folyóiratokban 1. Nádasdy T, Krenács T, Krenács L, Andó I. CD1 and S-100 positive cells in renal allografts. TISSUE ANTIGENS 33: 68 (1989) 2. Bhardwaj S, Krenács L, Krenács T, Andó I. Immunohistochemical studies with non-lineage new panel antibodies on paraffin-embedded human tonsil sections. TISSUE ANTIGENS 33: 288 (1989) 3. Krenács L, Krenács T, Andó I. Monoclonal antibodies to leukocyte antigens reacting in methacarn fixed, paraffin-embedded human tonsil. TISSUE ANTIGENS 33: 96 (1989) 4. Krenács L, Krenács T, Andó I. Diagnostic value of formaldehyde resistant T cell specific monoclonal antibodies (UCHL1, T2/48, T2/53) (poster presentation). PATH RES PRACT 185: 85 (1989) Abstract for XIIth European Congress of Pathology, Porto/Portugal, September Krenács T, Krenács L, Lászik Z, Bozóky B. Application of simultaneous immunocytochemical labelling at a light microscopic level in histopathology. PATH RES PRACT 185; 84 (1989) Abstract for XIIth European Congress of Pathology, Porto/Portugal, September Hamilton-Dutoit SJ, Sandvej K, Rindum J, Krenács L, Pindborg JJ, Pallesen G. Epstein-Barr virus gene expression in epithelial cells of oral hairy leukoplakia. PATH RES PRACT 187: (1991) Abstract for XIIIrd European Congress of Pathology, Ljubjana/Slovenia, 1991 (Congress was resigned) 7. Krenács L, Karsai L, Krenács T. Epstein-Barr virus and p53 over-expression in Hodgkin's disease (oral presentation). PATH RES PRACT 189: 734 (1993) Abstract for XIVth European Congress of Pathology, Innsbruck, Austria, September 5-10, Krenács T, Krenács L. Ubiquitination of vimentin intermediate filament in Hodgkin's disease in relation to the expression of Epstein-Barr virus latent membrane protein (poster presentation). PATH RES PRACT 189: (1993) Abstract for XIVth European Congress of Pathology, Innsbruck, Austria, September 5-10,

9 9. Krenács L, Raffeld M, Jaffe ES. Site-specific cytotoxic antigen expression in peripheral T- cell lymphomas. PATH RES PRACT 191: 703 (1995) XV European Congress of Pathology, Copenhagen, Denmark, September 5-8, Krenács L, Raffeld M, Jaffe ES. Cytotoxic cell-related antigen expression in anaplastic large cell lymphoma. MODERN PATHOL 9: 115 (1996) Abstract for the 85 th Annual Meeting of United States and Canadian Academy of Pathology at Washington, USA, March 23-29, Kumar S, Krenács L, Raffeld M, Elenitoba-Johnson KSJ, Greiner TC, Sorbara L, Kingma DW, Jaffe ES. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. MODERN PATHOL 10: 129 (1997) Abstract for the 86 th Annual Meeting of United States and Canadian Academy of Pathology, at Orlando, USA, Elenitoba-Johnson KSJ, Zarate-Osorno A, Meneses A, Krenács L, Kingma DW, Raffeld M, Jaffe ES. EBV strain type and LPM-1 oncogene deletions in nasal T/NK-cell lymphomas from Mexico. MODERN PATHOL 10: 12 (1997) Abstract for the 86 th Annual Meeting of United States and Canadian Academy of Pathology, at Orlando, USA, Campo E, Miguel R, Krenács L, Sorbara L, Raffeld M, Jaffe ES. Nodal marginal zone lymphomas of MALT and splenic type. MODERN PATHOL 11: 126 (1998) Abstract for the 87 th Annual Meeting of United States and Canadian Academy of Pathology at Boston, USA, February 28-March 6, Quintanilla-Martinez L, Guerrero JL, Franklin KN, Naresh L, Krenács L, Rama-Rao C, Bhatia K, Magrath IT, Raffeld M. Nasal NK/T-cell lymphoma from Peru High prevalence of p53 overexpression. MODERN PATHOL 11: 139 (1998) Abstract for the 87 th Annual Meeting of United States and Canadian Academy of Pathology at Boston, USA, February 28-March 6, Bagdi E, Krenács L, Sellei A, Tóth Zs, Lakos M, Gurbity PT. Immunopathological analysis of intestinal T-cell lymphomas: Cellular origin and association with celiac disease. Z GASTROENTEROL 38: A004 (2000) Abstract for the 42 nd Annual Meeting of the Hungarian Society of Gastroenterology at Balatonaliga, Hungary, June 6-8, Krenács L, Bagdi E, Gurbity PT, Tóth Zs, Sellei A, Lakos M, Borbenyi Z, Lonovics J. Helicobacter pylori and gastric MALT-lymphoma: A morphological and molecular genetic study. Z GASTROENTEROL 38: A061 (2000) Abstract for the 42 nd Annual Meeting of the Hungarian Society of Gastroenterology at Balatonaliga, Hungary, June 6-8, 2000 A PhD fokozat megszerzését követő időszak kutatói munkájának eredményei: 17. Krenács T, Bagdi E, Krenács L. Diagnostic immunophenotyping of bone marrow biopsies in semithin, epoxi-resin sections. PATHOL INT 50(Suppl): FP (2000) Abstract for the XXIII International Congress of the International Academy of Pathology at Nagoya, Japan, October 15-20, Gurbity PT, Bagdi E, Borbényi Z, Lonovics J, Krenács L. Detection of B-cell gene rearrangements in primary gastric non-hodgkin lymphomas. Z GASTROENTEROL 39: 392 (2000) Abstract No 049 Abstract for the 43 rd Annual Meeting of the Hungarian Society of Gastroenterology, Balatonaliga, Hungary, 5-9 June Krenács L, Bagdi E, Gurbity PT, Lakos M, Lonovics J. Immunophenotypic and molecular genetic study on intraepithelial T-lymphocytes in lymphocytic gastritis, celiac disease and intestinal T-cell lymphoma. Z GASTROENTEROL 39: A088 (2001) Abstract for the 43 rd Annual Meeting of the Hungarian Society of Gastroenterology, Balatonaliga, Hungary, 5-9 June

10 20. Piukovics K, Adamkovich N, Borbényi Z Gurbity PT, Krenács L, Modok Sz, Bagdi E, Varga Gy. Enteropathy associated T-cell lymphomas: Clinical experience. Z GASTROENTEROL 39: A (2000) Abstract for the 43 rd Annual Meeting of the Hungarian Society of Gastroenterology, Balatonaliga, Hungary, 5-9 June Bagdi E, Groen NA, Gurbity TP, Abbou M, DinjensWNM, Krenács L. Improved B-cell clonality analysis in gastric MALT lymphomas using rtth DNA polymerase. J CLIN PATH 55(Suppl I): A19(No067) (2002) Abstract for the XI Meeting of European Association for Haematopathology, Siena, Italy, May Gurbity TP, Bagdi E, Borbényi Z, Krenács L. Improved PCR-based (IgH and Ig kappa) B- cell clonality analysis in primary gastric B-cell lymphomas. ANN ONCOL 13(Suppl 2): 129(No452) (2002) Abstract for the 8 th International Conference on Malignant Lymphoma, Lugano, Switzerland, June Piukovics K, Adamkovich N, Borbényi Z, Bagdi E, Krenács L, Varga Gy. Enteropathy associated T-cell lymphomas: clinical experiences. ANN ONCOL 13(Suppl 2): p136 Abstract No478 (2002) Abstract for the 8 th International Conference on Malignant Lymphoma, Lugano, Switzerland, June Piukovics K, Borbényi Z, Bagdi E, Gurbity TP, Krenács L, Varga Gy. Coexistence of nodal anaplastic large cell lymphoma with enteropathy associated T-cell lymphoma: Case report. HEMAT J 3(Suppl I): 262(No0880) (2002) Abstract for the 7 th Meeting of European Hematology Association, Florence, Italy, 6-9 June Venkatraman L, McDonald KA, Bagdi E, Krenács L, Piggott N, McIntosh G, Dogan A. Characterisation of a new monoclonal antibody recognising CD11c in paraffinembedded tissue. Meeting Abstract MOD PATHOL 18: 255A-256A (2005) 26. Piukovics K, Borbényi Z, Bagdi E, Krenács L, Varga Gy. Primary aggressive gastric lymphomas Clinical experiences. Meeting Abstract ANN ONCOL 16: 162 (2005) 27. Krenács T, Pápay J, Molnár B, Moldvay J, Krenács L, Furák J, Kopper L. Studying tumor progression in non-small cell lunkg cancer by using tissue microarrays, virtual microscopy and new software tool. Meeting Abstract MOD PATHOL 19: 130 (2006) Nemzetközi konferenciák kiadványai 1. Krenács L, Krenács T. Cytochemical differential diagnosis of leukaemia cases (oral presentation). Freundschafts-Symposium, "Aktuelle Fragen der Pathologie", June, (1986) Halle, East-Germany. 2. Krenács L. Retroperitoneal eosinophilic myelosarcoma (oral presentation). Freundschafts- Symposium, June 3-5 (1988) Halle. East-Germany. 3. Krenács T, Krenács L, Molnár E, Dux L. Immunohistochemical studies on sarcoplasmic reticulum (SR) Ca2+-ATPase and myoglobin in normal and diseased muscles (poster presentation). XVIIth International Congress of the International Academy of Pathology (IAP) 4-9 Sept. (1988) Dublin, Ireland. 4. Krenács L, Krenács T. Primary gastrointestinal malignant lymphomas. Magyar Pathológusok Társasága Délalföldi Szekciója, Magyar Tudományos Akadémia Szegedi Bizottsága és Szent-Györgyi Albert Orvostudományi Egyetem Tudományos Ülései Bizottsága által szervezett Tudományos Ülés Szeged, (1989) június 1. 10

11 5. Krenács L, Andó I. Immunohistochemical study of certain lymphoid markers (oral presentation). XIth Meeting of the Polish Society of Pathologists, June (1989) Poznan/Poland. 6. Krenács T, Krenács L, Stiller D, Molnár E, Dux L. Sarcoplasmic reticulum Ca 2+ -ATPase as a new potential marker for rhabdomyosarcomas (oral presentation). XIth Meeting of the Polish Society of Pathologists, June (1989) Poznan, Poland. 7. Krenács L, Bagdi E. A study of gastrointestinal malignant lymphomas (poster presentation). IIIrd Meeting of the European Association for Haematopathology, Würzburg/Germany, (1990) 8. Krenács L. Immunohistochemical diagnosis of the primary gastrointestinal tumours (oral presentation). Palics, Jugoszlávia, (1990) 9. Krenács L, Bagdi E: A study of gastrointestinal malignant lymphomas (oral presentation). Aarhus, March, (1991) 10. Krenács L. Non-radioactive in situ hybridisation of Epstein-Barr virus (oral presentation). Szabadka, Jugoszlávia, (1991) 11. Krenács L. Non-radioactive in situ hybridisation of Epstein-Barr virus (oral presentation). Szegedi Akadémiai Bizottság Orvosi Szakbizottsága és Szent-Györgyi Albert Orvostudományi Egyetem Tudományos Ülései Bizottsága közös rendezvénye: Halle- Wittenberg-i Martin Luther Egyetem és SZOTE Pathológiai Intézetei munkatársainak előadásai. Szeged, (1991) október Kurucz E. Krenács L, Monostori É, Andó I. Similar histological and histochemical reactions of a CD3-epsilon chain antibody in phylogenetically distant species (poster presentation). VIIIth International Congress of Immunology, Budapest/Hungary, (1992) 13. Krenács L, Krenács T. The monoclonal antibody 0-10 marks CD1a antigen in routinely processed tissue (poster presentation). Vth Meeting of the European Association for Haematopathology, Bologna, Italy, (1992) 14. Krenács L, Krenács T. Epstein-Barr virus and overexpression of p53 oncoprotein in Hodgkin's disease (oral presentation). Croatian Days of Selected Topics in Medical Science, Zagreb, Croatia, November 19-22, (1993) 15. Krenács L, Krenács T. Analysis of Epstein-Barr virus gene expression in benign and malignant lymphoid tissues (poster presentation). VII Meeting of the EAHP, Toledo, Spain, Oct. 3-6, (1994) 16. Várkonyi Á, Krenács L, Boda M, Tímár E, Horváth I: Abdominal plasma-cell Castleman's disease in childhood - A big chalenge for gastro-enetrologists (oral presentation) 4 th Paediatric Alps-Adriatic Symposium, Szombathely, Hungary, June 22-23, (1995) 17. Krenács L, Himmelmann AW, Riva A, Kehrl JH, Jaffe ES, Raffeld M: Expression of the transcription factor BSAP in malignant lymphomas (poster presentation). VIIIth Meeting of the European Association for Haemotopathology, Paris, France, April 21-26, (1996) 18. Wellmann A, Thieblemont C, Krenács L, Fest T, Jaffe E. Detection of NPM-ALK rearrangements using an xl (extra large)-pcr assay and an analysis of genomic breakpoint sequences. 81 st German Congress for Pathology, Berlin, Germany, May 20-24, (1997) 11

12 19. Wellmann A, Krenacs L, Fest T, Scherf U, Pastan I, Raffeld M, Brinkmann U. Localization of the cell proliferation and apoptosis associated CAS protein in lymphoid neoplasms. 81 st German Congress for Pathology, Berlin, Germany, May 20-24, (1997) 20. Krenacs L, Jaffe ES, Raffeld M. Himmelmann AW, Riva A, Kehrl JH, Jaffe ES, Raffeld M: Expression of the granular lymphocyte proteins (TIA-1/GMP-17, perforin and metase) in peripheral T-cell lymphomas (oral presentation). IXth Meeting of the European Association for Haemotopathology, Leiden, The Netherlands, April (1998) 21. Krenacs L, Bagdi E, Sellei A, Toth Zs. Intestinal T-cell Lymphoma: Its Cytotoxic Lymphocyte Phenotype and Association with Coeliac Disease. Poster presentation on the 8 th International Symposium on Celiac Disease, Naples, Italy, April (1999) Abstract Book 050, pp Krenács L, Bagdi E, Sellei A, Toth Zs, Krenacs T. Monoclonal antibody HBME-1 is a marker of villous B-lymphocytes: are these cells the precursors of hairy cell leukaemia? X. Meeting of European Association for Haematopathology, May 7-11, (2000) London, England. 23. Krenacs T, Krenacs L, Bagdi E, Becker DL. Gap junctional communication in the lymphoid germinal centre. X. Meeting of European Association for Haematopathology, May 7-11, (2000) London, England. 24. Bagdi E, Krenács L, Krenacs T, Miller K, Isaacson PG. Follicular Dendritic Cells in Reactive and Neoplastic Lymphoid Tissues: A Re-evaluation of Staining Patterns of CD21, CD23 and CD35 Antigens in Formalin-Fixed Paraffin Sections after Heat-Induced Epitope Retrieval. X. Meeting of European Association for Haematopathology, May 7-11, (2000) London, England. A PhD fokozat megszerzését követő időszak kutatói munkájának eredményei: 25. Krenacs T, Bagdi E, Krenacs L. Diagnostic immunophenotyping of bone marrow biopsies in semithin, epoxi-resin sections. Paper presentation on the XXIII International Congress of the International Academy of Pathology, Nagoya, Japan, October (2000) Abstract Book A136 (FP-16-24). 26. Krenacs L, Bagdi E. Expression pattern of granular lymphocyte proteins in peripheral T- cell lymphomas. Invited paper presentation on the Hematopathology Tutorial under the auspicies of the European Association for Hematopathology - Symposium, Pecs, Hungary, 9-12 April (2001) 27. Krenacs L, Bagdi E. Pathology of indolent B-cell lymphomas. Invited paper presentation on the Hematopathology Tutorial under the auspicies of the European Association for Hematopathology - Symposium, Pecs, Hungary, 9-12 April (2001) 28. Krenacs L, Bagdi E. Acute eosinophilic leukemia case presentation and review of the literature. Paper presentation on the 4 th Scientific Meeting of the European Bone Marrow Working Group (EBWG), Basel, Switzerland, June (2002) 29. Krenacs L, Bagdi E: Immunomorphology of hairy cell leukaemia in the bone marrow. Paper presentation on the EAHP/European Bone Marrow Working Group Meeting, Stockholm, Sweden, June (2004) 30. Torok L, Krenacs L, Kocsis L, Bagdi E. Agranular CD4+, CD56+ hematodermic neoplasm. Poster presentation on the International Skin Cancer Conference, Zurich, Switzerland, July (2004) 12

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:

More information

Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma (CALM) Additional Questionnaire (MED C) INCLUSION CRITERIA CALM STUDY

Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma (CALM) Additional Questionnaire (MED C) INCLUSION CRITERIA CALM STUDY Additional Questionnaire (MED C) CALM study Inclusion period: 01/01/2008 to 31/12/2011 PATIENT REGISTRATION FORM Disease Diagnosis Lymphoma S Non Hodgkin Lymphoma (NHL) Mature B-cell neoplasm Follicular

More information

MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)

MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010) MALIGNANT LYMPHOMAS Dr. Olga Vujovic (Updated August 2010) Malignant lymphomas consist of Hodgkin and non-hodgkin lymphomas. The current management of these diseases involves a multi-disciplinary approach.

More information

Non-Hodgkin s Lymphoma

Non-Hodgkin s Lymphoma Non-Hodgkin s Lymphoma Luis Fayad, MD Assistant Professor Clinical Medical Director Lymphoma/Myeloma Department Non-Hodgkin s Lymphoma Non-Hodgkin s lymphomas (NHL) are a heterogeneous group of malignant

More information

Lymphoma Diagnosis and Classification

Lymphoma Diagnosis and Classification Lymphoma Diagnosis and Classification By Atef Shrit, MD, Pathology B- and T/NK-cell lymphomas are clonal neoplasms of immature and mature B-lymphocytes, T-lymphocytes or natural killer cells at various

More information

Malignant Lymphomas and Plasma Cell Myeloma

Malignant Lymphomas and Plasma Cell Myeloma Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations

More information

Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms. Dr. Douaa Mohammed Sayed

Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms. Dr. Douaa Mohammed Sayed Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms Dr. Douaa Mohammed Sayed Small lymphocytic lymphoma/b-cell chronic lymphocytic leukemia BMB: nodular, interstitial, diffuse or a combination

More information

Oncology Best Practice Documentation

Oncology Best Practice Documentation Oncology Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Solid Tumors Lymphomas Leukemias Myelodysplastic Syndrome Pathology Findings

More information

OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE SUBSETS AND THEIR FUNCTIONS OVERVIEW OF NORMAL LYMPH

OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE SUBSETS AND THEIR FUNCTIONS OVERVIEW OF NORMAL LYMPH AN INTRODUCTION TO THE LYMPHOPROLIFERATIVE DISORDERS BY DR Y PERNER DEPARTMENT OF ANATOMICAL PATHOLOGY OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE

More information

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Aggressive lymphomas. Michael Crump Princess Margaret Hospital Aggressive lymphomas Michael Crump Princess Margaret Hospital What are the aggressive lymphomas? Diffuse large B cell Mediastinal large B cell Anaplastic large cell Burkitt lymphoma (transformed lymphoma:

More information

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes

More information

亞 東 紀 念 醫 院 Follicular Lymphoma 臨 床 指 引

亞 東 紀 念 醫 院 Follicular Lymphoma 臨 床 指 引 前 言 : 惡 性 淋 巴 瘤 ( 或 簡 稱 淋 巴 癌 ) 乃 由 體 內 淋 巴 系 統 包 括 淋 巴 細 胞 淋 巴 管 淋 巴 腺 及 一 些 淋 巴 器 官 或 組 織 如 脾 臟 胸 腺 及 扁 桃 腺 等 所 長 出 的 惡 性 腫 瘤 依 腫 瘤 病 理 組 織 型 態 的 不 同 可 分 為 何 杰 金 氏 淋 巴 瘤 (Hodgkin s disease) 與 非 何 杰 金

More information

A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on

A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on examination. She also has fever, weight loss, and sweats. What

More information

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA Interesting Case Review Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA History 63 y/o male with h/o CLL for 10 years Presents with worsening renal function and hypercalcemia

More information

Immunohistochemical classification of malignant lymphomas

Immunohistochemical classification of malignant lymphomas Immunohistochemical classification of malignant lymphomas Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Thanks to Jan Klos Important issues Distinction from non-hematopoietic neoplasms

More information

Practical Effusion Cytology

Practical Effusion Cytology Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.

More information

About B Cell Lymphomas Groupmeeting Klipp/Spang, December 09 2002 Dennis Kostka Max-Planck-Institute for Molecular Genetics Computational Molecular Biology Berlin 1 Overview Short History of Lymphoma Classification

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Leukemias and Lymphomas: A primer

Leukemias and Lymphomas: A primer Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes

More information

Ki-1 Large Cell Anaplastic Lymphoma - A Clinicopathological Study

Ki-1 Large Cell Anaplastic Lymphoma - A Clinicopathological Study Ki-1 Large Cell Anaplastic Lymphoma - A Clinicopathological Study Pages with reference to book, From 169 To 171 Sajid Mushtaq, Iftikhar A. Malik, Manzoor Ahmed, M. Safdar Khan, Amir Hussain Khan, Shahid

More information

Bone Marrow Evaluation for Lymphoma. Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital

Bone Marrow Evaluation for Lymphoma. Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital Bone Marrow Evaluation for Lymphoma Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital Indications One of the most common indications for a bone marrow biopsy is to evaluate for malignant lymphoma.

More information

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart

More information

Two Retroperitoneal Low-Grade B-Cell Lymphoma Successfully Treated With a Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy

Two Retroperitoneal Low-Grade B-Cell Lymphoma Successfully Treated With a Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy Two Retroperitoneal Low-Grade B-Cell Lymphoma Successfully Treated With a Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy Yoichi Kitamura, MD Kazuhiko Hayashi, MD Kazumi Uchida,

More information

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Anatomic Pathology / TTF-1 IN CYTOLOGY OF BODY FLUIDS The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Jonathan L. Hecht, MD,

More information

PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA

PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA 2012 1 31,, PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA Version 1.0 2012 DIVISION OF HAEMATOLOGY / ONCOLOGY DEPARTMENT OF MEDICINE KAOHSING VETERAN GENERAL HOSPTIAL General Guide Diagnosis 1.Adequate

More information

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion. Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case

More information

The use of monoclonal antibodies in the setting of HSCT

The use of monoclonal antibodies in the setting of HSCT The use of monoclonal antibodies in the setting of HSCT S Montoto, Barts Cancer Institute, London, UK Geneva 3/April/2012 www.ebmt.org Some definitions of interest: Ab and Ag Antibody (Ab)=Immunoglobulin

More information

The Diagnosis of Cancer in the Pathology Laboratory

The Diagnosis of Cancer in the Pathology Laboratory The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens

More information

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic Pulling the Plug on Cancer Cell Communication Stephen M. Ansell, MD, PhD Mayo Clinic Why do Waldenstrom s cells need to communicate? Waldenstrom s cells need activating signals to stay alive. WM cells

More information

Microbiology AN INTRODUCTION EIGHTH EDITION

Microbiology AN INTRODUCTION EIGHTH EDITION TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein

More information

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham An overview of CLL care and treatment Dr Dean Smith Haematology Consultant City Hospital Nottingham What is CLL? CLL (Chronic Lymphocytic Leukaemia) is a type of cancer in which the bone marrow makes too

More information

Chapter 43: The Immune System

Chapter 43: The Immune System Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2

More information

Excellent FFPE. Staining

Excellent FFPE. Staining Outstanding Markers Excellent FFPE Staining Superior Staining Quality High Titer Best Price O P T I S TA I N Anti-PD-1 (clone NAT105) - a marker for follicular helper T cells (T FH ) and T-cell lymphomas

More information

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics Page 1 IKDT Laboratory IKDT as Service Lab (CRO) for Molecular Diagnostics IKDT lab offer is complete diagnostic service to all external customers. We could perform as well single procedures or complex

More information

In extenso papers, basis of the dissertation (found in Appendix)

In extenso papers, basis of the dissertation (found in Appendix) LIST OF PUBLICATIONS In extenso papers, basis of the dissertation (found in Appendix) 1. Molnár Zs. Positron emission Tomography (PET) in diagnosis and clinical management of malignant lymphomas. Haemat

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

Non Hodgkin Lymphoma:

Non Hodgkin Lymphoma: Non Hodgkin Lymphoma: Non Hodgkin Lymphoma, often referred to as NHL, is a cancer originating in the lymphocytes, a type of blood cell, which are integral to the body s immune system. Non Hodgkin Lymphoma

More information

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy

More information

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015 The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response

More information

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders UPDATE ECIL-4 2011 2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders Jan Styczynski, Hermann Einsele, Rafael de la Camara, Catherine Cordonnier,

More information

Immunohistochemical differentiation of metastatic tumours

Immunohistochemical differentiation of metastatic tumours Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in

More information

Pathology of lung cancer

Pathology of lung cancer Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

VIRUSES AND CANCER. Michael Lea

VIRUSES AND CANCER. Michael Lea VIRUSES AND CANCER 2012 Michael Lea VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses HISTORICAL REVIEW Historical Review

More information

Anti-HCV therapy in HCV-related NHL

Anti-HCV therapy in HCV-related NHL Gabriele Pozzato M.D. University of Trieste Anti-HCV therapy in HCV-related NHL Questions about HCV+ in NHL Is the NHL related with HCV infection? Which is the best therapeutic strategy? Is the antiviral

More information

Lymphomas after organ transplantation

Lymphomas after organ transplantation Produced 21.03.2011 Revision due 21.03.2011 Lymphomas after organ transplantation People who have undergone an organ transplant are more at risk of developing lymphoma known as post-transplant lymphoproliferative

More information

B Cells and Antibodies

B Cells and Antibodies B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production

More information

Veterinary Testing. Classes of Test

Veterinary Testing. Classes of Test Veterinary Testing Classes of Test July 2014 Copyright National Association of Testing Authorities, Australia 2014 This publication is protected by copyright under the Commonwealth of Australia Copyright

More information

http://www.springer.com/3-540-22006-2

http://www.springer.com/3-540-22006-2 http://www.springer.com/3-540-22006-2 1 Molecular Pathology Laboratory of the Future Christopher A. Moskaluk 1.1 The Past The integration of laboratory analysis with human medicine has traditionally been

More information

CLL/SLL. Clinical Aspects of CLL/SLL CLL/SLL. CLL/SLL definition (WHO 2008) The Immunology of Chronic Lymphocytic Leukemia.

CLL/SLL. Clinical Aspects of CLL/SLL CLL/SLL. CLL/SLL definition (WHO 2008) The Immunology of Chronic Lymphocytic Leukemia. The Immunology of Chronic Lymphocytic Leukemia Megan S. Lim MD PhD Professor Director of Division of Hematopathology (HUP/CHOP) Director of Lymphoma Biology Program ASCLS Annual Meeting August 3, 2016

More information

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer

More information

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Department of Pathology University of Szeged, Hungary ISUP Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37:14691489, 2013 13 histologic

More information

A 70-year old Man with Pleural Effusion

A 70-year old Man with Pleural Effusion Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which

More information

B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2008 WHO Classification of Lymphoid Neoplasms: Small B-Cell Neoplasms Chronic lymphocytic leukemia/small lymphocytic lymphoma B-cell prolymphocytic leukemia Splenic marginal zone B-cell lymphoma Hairy

More information

Interesting Case Series. Periorbital Richter Syndrome

Interesting Case Series. Periorbital Richter Syndrome Interesting Case Series Periorbital Richter Syndrome MarkGorman,MRCS,MSc, a Julia Ruston, MRCS, b and Sarath Vennam, BMBS a a Division of Plastic Surgery, Royal Devon and Exeter Hospital, Exeter, Devon,

More information

Human Immunity. How our body s cells defend against microbial and viral invaders

Human Immunity. How our body s cells defend against microbial and viral invaders Human Immunity How our body s cells defend against microbial and viral invaders What is Immunity? The word immunity comes from the Latin immunus meaning free of burden. Thus; it is a body s general ability

More information

Activation and effector functions of HMI

Activation and effector functions of HMI Activation and effector functions of HMI Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 August 2015 ว ตถ ประสงค หล งจากช วโมงบรรยายน แล วน กศ กษาสามารถ

More information

CutaneousLymphoma Overview and Early Diagnosis

CutaneousLymphoma Overview and Early Diagnosis CutaneousLymphoma Overview and Early Diagnosis Mara Haseltine, MD/MPH, FAAD Assistant Clinical Professor of Dermatology at Tulane Medical Center and LSU Health Sciences Center Poole Dermatology, APMC Our

More information

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%

More information

Lymphoplasmacytic Lymphoma. Hematology fellows conference 4/12/2013 Christina Fitzmaurice, MD, MPH

Lymphoplasmacytic Lymphoma. Hematology fellows conference 4/12/2013 Christina Fitzmaurice, MD, MPH Lymphoplasmacytic Lymphoma versus IGM Multiple Myeloma Hematology fellows conference 4/12/2013 Christina Fitzmaurice, MD, MPH Hematology consult patient 48 yo woman presents to ER with nonspecific complaints:

More information

H ODGKIN AND NON-HODGKIN LYMPHOMA STAGING FORM

H ODGKIN AND NON-HODGKIN LYMPHOMA STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery PRIMARY TUMOR (T) No T category exists for Hodgkin and Non-Hodgkin Lymphoma

More information

20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.

20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC. Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains in Differentiating Adenocarcinoma, Squamous Cell Carcinoma, and Malignant Mesothelioma in Effusions Robert T. Pu,

More information

Product Datasheet and Instructions for Use

Product Datasheet and Instructions for Use Product Code: MP-092-CR01 (0.1ml concentrate) MP-092-CR05 (0.5ml concentrate) MP-092-CR1 (1ml concentrate) MP-092-PR6 (6ml RTU) Product Description: Calretinin Concentrated and Prediluted Polyclonal Antibody

More information

Test 4 Immune System (Chapters 20 & 21)

Test 4 Immune System (Chapters 20 & 21) Test 4 Immune System (Chapters 20 & 21) Name: Date: 1) The is the largest lymphoid organ. 1) A. lymph node B. spleen C. thymus D. tonsil 2) Tonsils promote memory of pathogens by. 2) A. secreting antibodies

More information

FNA cytology of lymphomas: useless or useful? Edneia Tani

FNA cytology of lymphomas: useless or useful? Edneia Tani FNA cytology of lymphomas: useless or useful? Edneia Tani Karolinska University Hospital Stockholm Sweden FNAC LYMPH NODE First report: FNAC LYMPH NODE Pioneers Sixten Franzén Lopez Cardoso FNAC LYMPH

More information

Pediatric Oncology for Otolaryngologists

Pediatric Oncology for Otolaryngologists Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department

More information

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine

More information

The Role of Interleukin-8 in the Progression of Malignant Mesothelioma

The Role of Interleukin-8 in the Progression of Malignant Mesothelioma Ph. D. Thesis The Role of Interleukin-8 in the Progression of Malignant Mesothelioma Gabriella Gálffy M.D. Semmelweis University, School of PhD Studies Consultant: Prof. Pál Magyar M.D. Budapest, 2001

More information

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc. Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

More information

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED? WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED? Which test should be submitted? The answer to this depends on the clinical signs, and the diagnostic question you are asking. If

More information

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and Blood Disorders La Crosse, WI UNDERSTANDING MULTIPLE

More information

Flow Cytometric Evaluation of B-cell Lymphoid Neoplasms

Flow Cytometric Evaluation of B-cell Lymphoid Neoplasms Clin Lab Med 27 (2007) 487 512 Flow Cytometric Evaluation of B-cell Lymphoid Neoplasms Fiona E. Craig, MD Division of Hematopathology, Department of Pathology, University of Pittsburgh School of Medicine,

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LEUKEMIA CHAPTER 11A REVISED: OCTOBER 2015

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LEUKEMIA CHAPTER 11A REVISED: OCTOBER 2015 LEUKEMIA Response in Acute Myeloid Leukemia (AML) Response criteria in Acute Myeloid Leukemia for SWOG protocols is based on the review article Diagnosis and management of acute myeloid leukemia in adults:

More information

Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Catania

Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Catania Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Neoplasia gastrica cistica: GIST o leiomiosarcoma? Aims of presentation Atypical

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data

Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data (Form 2018) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data Form. E-mail comments regarding the content

More information

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Verónica Cánovas, PhD Student Laboratory of Cell Signalling and Cancer Progression, Dra. Rosanna Paciucci

More information

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the

More information

Epstein-Barr virus-associated lymphoproliferative disease following allogeneic stem cell transplantation

Epstein-Barr virus-associated lymphoproliferative disease following allogeneic stem cell transplantation Epstein-Barr virus-associated lymphoproliferative disease following allogeneic stem cell transplantation Dr Christopher Fox Consultant Haematologist Nottingham University Hospitals NHS Trust The Herpesvirus

More information

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used? Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or

More information

Understanding Non-Hodgkin Lymphoma

Understanding Non-Hodgkin Lymphoma Understanding Non-Hodgkin Lymphoma A Guide For Patients, Survivors, and Loved Ones Fourth Edition This guide is an educational resource compiled by the Lymphoma Research Foundation (LRF) that provides

More information

The Immune System: A Tutorial

The Immune System: A Tutorial The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The

More information

Neoplasms. Review of Normal Cells. Bio 375 Pathophysiology

Neoplasms. Review of Normal Cells. Bio 375 Pathophysiology Neoplasms Bio 375 Pathophysiology Review of Normal Cells During its life span, each cell follows the basic cell cycle of growth and reproduction called mitosis The timing of each event varies with the

More information

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually

More information

PNL2 MELANOCYTIC MARKER IN IMMUNOHISTOCHEMICAL EVALUATION OF PRIMARY MUCOSAL MELANOMA OF THE HEAD AND NECK

PNL2 MELANOCYTIC MARKER IN IMMUNOHISTOCHEMICAL EVALUATION OF PRIMARY MUCOSAL MELANOMA OF THE HEAD AND NECK ORIGINAL ARTICLE PNL2 MELANOCYTIC MARKER IN IMMUNOHISTOCHEMICAL EVALUATION OF PRIMARY MUCOSAL MELANOMA OF THE HEAD AND NECK Luc G. Morris, MD, 1 Yong Hannah Wen, MD, PhD, 2 Daisuke Nonaka, MD, 2 Mark D.

More information

Multiple Myeloma Patient s Booklet

Multiple Myeloma Patient s Booklet 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore 119228 Email : ncis@nuhs.edu.sg Website : www.ncis.com.sg LIKE US ON FACEBOOK www.facebook.com/ nationaluniversitycancerinstitutesingapore Multiple

More information

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells Key anatomical sites

More information

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957

More information

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014 General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention

More information

Articles. Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance. Mogens Vyberg, MD

Articles. Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance. Mogens Vyberg, MD Articles Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance Mogens Vyberg, MD Institute of Pathology. Aalborg Hospital Aarhus University Hospital Denmark

More information

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

This module consists of four units which will provide the user a basic knowledge of cancer as a disease. Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

NEU IM PROGRAMM. LOXO Antikörper für die Immunhistochemie (alphabetisch nach Bezeichnung sortiert) Art.Code Artikelbezeichnung Typ Einsatz Einheit

NEU IM PROGRAMM. LOXO Antikörper für die Immunhistochemie (alphabetisch nach Bezeichnung sortiert) Art.Code Artikelbezeichnung Typ Einsatz Einheit A20002 Actin, Alpha-Smooth Muscle; Clone 1A4 monoklonal IHC 2 ml Ready-to-use A00002.0025 Actin, Alpha-Smooth Muscle; Clone 1A4 monoklonal IHC 25 ml Ready-to-use A00002 Actin, Alpha-Smooth Muscle; Clone

More information

Agnes Csikos MD, PhD

Agnes Csikos MD, PhD Agnes Csikos MD, PhD Personal Details Date of birth: March 8, 1970, Pecs Nationality: Hungarian Marital Status:Married Children: Kata 1996, Panna 1999, Tamas 2004 Address: 24 Radnics Street 7624 Pecs Hungary

More information

Non-Hodgkin Lymphoma Richard Orlowski, MD

Non-Hodgkin Lymphoma Richard Orlowski, MD Non-Hodgkin Lymphoma Richard Orlowski, MD The American Cancer Society (ACS) estimates that 69,740 Americans will be diagnosed with non-hodgkin lymphoma (NHL) in 2013. Excluding non-melanoma skin cancers,

More information

Effusions of the Serous Cavities

Effusions of the Serous Cavities Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura

More information

OCCULT PRIMARY CANCER

OCCULT PRIMARY CANCER OCCULT PRIMARY CANCER พญ.ครองกมล ส หบ ณฑ หน วยมะเร งว ทยา INTRODUCTION Occult primary cancers or cancer of unknown primary (CUPS) Histologically proven metastatic malignant tumors whose primary site cannot

More information